Clinical and Experimental Vaccine Research

  • 제11권2호
  • /
  • Pages.193-208
  • /
  • 2022
  • /
  • 2287-3651(pISSN)
  • /
  • 2287-366X(eISSN)
대한백신학회 (The Korean Vaccine Society)
권호 표지
DOI QR코드

DOI QR Code

Exploring the myths surrounding the COVID-19 vaccines in Africa: the study to investigate their impacts on acceptance using online survey and social media

  • Emmanuel Lamptey (Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan) ;
  • Ephraim Kumi Senkyire (Ga-West Municipal Hospital, Ghana Health Service) ;
  • Serwaa Dorcas (Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan) ;
  • Dooshima Aki Benita (Department of Psychology, Benue State University) ;
  • Evans Osei Boakye (Department of Social Work, University of Ghana) ;
  • Theckla Ikome (Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan) ;
  • Alex Asamoah (Shai Osudoku District Hospital, Ghana Health Service)
  • 투고 : 2021.07.11
  • 심사 : 2021.09.03
  • 발행 : 2022.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The coronavirus disease 2019 (COVID-19) vaccine is the key to getting out of the pandemic. However, acceptance of the vaccine has been affected by false information and rumors, which have kept people from getting the shot since it was rolled out. Materials and Methods: This study aimed to investigate the various misconceptions surfaced about the COVID-19 vaccines in Africa. We performed an online survey using an anonymous questionnaire to reach out to African respondents by social media and all possible online platforms such as Facebook, WhatsApp, Instagram, Twitter, YouTube, and so forth. The web-based questionnaires about the myths surrounding the vaccines were extracted from nonscientific information, unproven statements, social media posts, news reports, and people's concerns about the safety of the COVID-19 vaccines. Participants indicated their level of agreement with each statement. Results: A total of 2,500 people responded to the online survey in Africa. The two common myths that respondents agreed with were that "since vaccines for COVID-19 have been developed, we can make vaccines for the common cold, human immunodeficiency viruses, and other diseases" (n=892, 35.7%) and that "researchers rushed the development of the COVID-19 vaccines; therefore, it is not very effective, safe and cannot be trusted" (n=595, 23.8%). The range of respondents who neither agreed nor disagreed with these myths was 12.4%-33.0%. The majority (1,931, 77.2%) indicated disagreement with the statement "after getting the COVID-19 vaccine, one can stop wearing a mask as well as taking safety precautions." Conclusion: Myths surrounding the COVID-19 vaccines have impact on acceptance. Exploring them helps public health authorities in Africa dispel them and provide accurate information to promote vaccination campaigns, education, and acceptance.

키워드

참고문헌

  1. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis 2020;20:773. 
  2. Corbett KS, Flynn B, Foulds KE, et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N Engl J Med 2020;383:1544-55. 
  3. World Health Organization. COVID-19 vaccine tracker and landscape [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Mar 7]. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. 
  4. Centers for Disease Control and Prevention. About COVID-19 vaccines [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2021 May 27]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html#about-vaccines. 
  5. Betsch C, Bohm R, Korn L, Holtmann C. On the benefits of explaining herd immunity in vaccine advocacy. Nat Hum Behav 2017;1:0056. 
  6. Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis 2020;26:1470-7. 
  7. Craven J. COVID-19 vaccine tracker [Internet]. Rockville (MD): Regulatory Affairs Professionals Society; [date unknown] [cited 2021 Jul 9]. Available from: https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker. 
  8. World Health Organization. 172 Countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility [Internet]. Geneva: World Health Organization; 2020 [cited 2021 Jul 9]. Available from: https://www.who.int/news/item/24-08-2020-172-countries-and-multiple-candidate-vaccines-engaged-in-covid-19-vaccine-global-access-facility. 
  9. Centers for Disease Control and Prevention. Benefits of getting vaccinated [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2021 Jul 9]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html. 
  10. Praveen SV, Ittamalla R, Deepak G. Analyzing the attitude of Indian citizens towards COVID-19 vaccine: a text analytics study. Diabetes Metab Syndr 2021;15:595-9. 
  11. Chou WS, Budenz A. Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun 2020;35:1718-22. 
  12. Afolabi AA, Ilesanmi OS. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J 2021;38:3. 
  13. Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med 2007;4:e73. 
  14. Febir LG, Asante KP, Dzorgbo DB, Senah KA, Letsa TS, Owusu-Agyei S. Community perceptions of a malaria vaccine in the Kintampo districts of Ghana. Malar J 2013;12:156. 
  15. Okunlola MA, Lamptey E, Senkyire EK, Dorcas S, Dooshima BA. Perceived myths and misconceptions about the novel COVID-19 outbreak. SciMed J 2020;2:108-17. 
  16. Ipsos. US and UK are optimistic indicators for COVID-19 vaccination uptake [Internet]. Paris: Ipsos; 2020 [cited 2021 Jul 9]. Available from: https://www.ipsos.com/en/global-attitudes-covid-19-vaccine-december-2020. 
  17. Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine 2020;38:7002-6. 
  18. Mwai P. COVID-19 vaccinations: African nations miss WHO target. BBS News [Internet]. 2021 Dec 31 [cited 2021 Jul 9]. Available from: https://www.bbc.com/news/56100076. 
  19. Africa CDC. COVID 19 vaccine perceptions: a 15 country study [Internet]. Addis Ababa: African Union; 2021 [cited 2021 Jul 9]. Available from: https://africacdc.org/download/covid-19-vaccine-perceptions-a-15-country-study/. 
  20. Hager E, Odetokun IA, Bolarinwa O, Zainab A, Okechukwu O, Al-Mustapha AI. Knowledge, attitude, and perceptions towards the 2019 coronavirus pandemic: a bi-national survey in Africa. PLoS One 2020;15:e0236918. 
  21. Kelen GD, Maragakis L. COVID-19 vaccines: myth versus fact [Internet]. Baltimore (MD): Johns Hopkins Medicine; 2021 [cited 2021 Jul 9]. Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/covid-19-vaccines-myth-versus-fact. 
  22. Verger P, Dube E. Restoring confidence in vaccines in the COVID-19 era. Expert Rev Vaccines 2020;19:991-3. 
  23. Shen AK. Finding a way to address a wicked problem: vaccines, vaccination, and a shared understanding. Hum Vaccin Immunother 2020;16:1030-3. 
  24. Kata A. Anti-vaccine activists, Web 2.0, and the postmodern paradigm: an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine 2012;30:3778-89. 
  25. Betsch C, Brewer NT, Brocard P, et al. Opportunities and challenges of Web 2.0 for vaccination decisions. Vaccine 2012;30:3727-33. 
  26. Gray KJ, Bordt EA, Atyeo C, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol 2021;225:303. 
  27. Centers for Disease Control and Prevention. COVID-19 Vaccines While Pregnant or Breastfeeding [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2021 Jul 9]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html. 
  28. American College of Obstetricians and Gynecologists' Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group, Riley LE, Beigi R, et al. COVID-19 vaccination considerations for obstetric-gynecologic care [Internet]. Washington (DC): American College of Obstetricians and Gynecologists; 2021 [cited 2021 Jul 8]. Available from: https://www.acog.org/en/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologiccare. 
  29. Society for Maternal-Fetal Medicine. COVID-19 vaccines and pregnancy [Internet]. Washington (DC): Society for Maternal-Fetal Medicine; [cited 2021 Jul 8]. Available from: https://www.highriskpregnancyinfo.org/covid-19-pregnancy. 
  30. Kim YC, Dema B, Reyes-Sandoval A. COVID-19 vaccines: breaking record times to first-in-human trials. NPJ Vaccines 2020;5:34. 
  31. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice, et al. Framework for equitable allocation of COVID-19 vaccine [Internet]. Washington (DC): National Academies Press; 2020 [cited 2021 Jul 8]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562672/. 
  32. Maruggi G, Zhang C, Li J, Ulmer JB, Yu D. mRNA as a transformative technology for vaccine development to control infectious diseases. Mol Ther 2019;27:757-72. 
  33. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 2020;383:2603-15. 
  34. Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines: a new era in vaccinology. Nat Rev Drug Discov 2018;17:261-79. 
  35. Glanville D. COVID-19 vaccines: development, evaluation, approval and monitoring [Internet]. Amsterdam: European Medicines Agency; 2020 [cited 2021 Jul 8]. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-development-evaluation-approval-monitoring. 
  36. Anyiam-Osigwe T. What you need to know about COVID-19 vaccine approvals in Nigeria and South Africa [Internet]. Washington (DC): GAVI; 2020 [cited 2021 Jul 9]. Available from: https://www.gavi.org/vaccineswork/what-you-need-know-about-covid-19-vaccine-approvals-nigeria-and-south-africa. 
  37. Ghana Food and Drugs Authority. Safetywatch update no.1: COVID-19 vaccine safety monitoring update [Internet]. Accra: Ghana Food and Drugs Authority; 2021 [cited 2021 Jul 9]. Available from: http://fdaghana.gov.gh/news-media.php?page=78. 
  38. Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc 2020;13:1657-63. 
  39. World Health Organization. COVAX Joint Statement: call to action to equip COVAX to deliver 2 billion doses in 2021 [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Jul 9]. Available from: https://www.who.int/news/item/27-05-2021-covax-joint-statement-call-to-action-to-equip-covax-to-deliver-2-billion-doses-in-2021.